IACB

4 - Innovid Corp. (0001835378) (Issuer)

4 - Innovid Corp. (0001835378) (Issuer)

4 - Innovid Corp. (0001835378) (Issuer)

3 - Innovid Corp. (0001835378) (Issuer)

3 - Innovid Corp. (0001835378) (Issuer)

3 - Innovid Corp. (0001835378) (Issuer)

3 - Innovid Corp. (0001835378) (Issuer)

3 - Innovid Corp. (0001835378) (Issuer)

3 - Innovid Corp. (0001835378) (Issuer)

3 - Innovid Corp. (0001835378) (Issuer)

25-NSE - Innovid Corp. (0001835378) (Subject)

8-K - Innovid Corp. (0001835378) (Filer)

  Gainers Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) shares climbed 128.6% to close at $5.03 on Tuesday. The FDA approved expanded labeling for Cumberland Pharmaceuticals’ Caldolor, an intravenously delivered formulation of ibuprofen, to now include use in pre-operative administration. MEI Pharma, Inc. (NASDAQ:MEIP) jumped 37.6% to settle at $3.37. MEI Pharma and Kyowa Kirin Co announced data from the pivotal Phase 2 TIDAL studyof zandelisib as a single agent for follicular lymphoma (FL) patients who received at least two prior systemic therapies. Pioneer Power Solutions, Inc. (NASDAQ:PPSI) shares gained 32.5% to close at $10.11 after dipping 27% on Monday. NuZee, Inc. (NASDAQ:NU

8-K - Innovid Corp. (0001835378) (Filer)

ION Acquisition Corp 2, Ltd. ("ION") (NYSE:IACB), a special purpose acquisition company, announced today that its shareholders voted to approve the previously announced business combination with Innovid Inc. ("Innovid" or the "Company"), a leading independent connected TV (CTV) advertising delivery and measurement platform, at its Extraordinary General Meeting held on November 29, 2021. Approximately 97.4% of the votes cast at the meeting voted to approve the transaction. The closing of the business combination is expected to take place on November 30. The transaction will generate approximately $251 million of proceeds upon closing, after giving effect to redemptions (of 19,585,174 shares

10-Q/A - ION Acquisition Corp 2 Ltd. (0001835378) (Filer)

8-K - ION Acquisition Corp 2 Ltd. (0001835378) (Filer)

Revenue of $64.3 million is up 41% over last year, driven by 65% growth in revenue from CTV Adjusted EBITDA of $3.7 million surges 201% vs. one year ago, representing a 6% adjusted EBITDA margin Expected to start trading as Innovid, under the new ticker symbol "CTV" on December 1, 2021, after completing a merger with ION Acquisition Corp. 2 Ltd. NEW YORK, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Innovid, a leading independent connected TV (CTV) advertising delivery and measurement platform, reports results for the nine months ended September 30, 2021, as part of its planned merger with ION Acquisition Corp. 2 Ltd. ("ION") (NYSE:IACB). The combined company will operate under the Innovid name an

425 - ION Acquisition Corp 2 Ltd. (0001835378) (Subject)

8-K - ION Acquisition Corp 2 Ltd. (0001835378) (Filer)

10-Q - ION Acquisition Corp 2 Ltd. (0001835378) (Filer)

EFFECT - ION Acquisition Corp 2 Ltd. (0001835378) (Filer)

Special meeting of ION Acquisition Corp 2 Ltd.'s stockholders to approve the proposed business combination with Innovid, Inc. to be held on November 29, 2021 ION Acquisition Corp 2 Ltd. (NYSE:IACB, IACB and IACB WS))) ("ION"), a publicly-traded special purpose acquisition company, and Innovid, Inc. ("Innovid"), a leading independent connected TV (CTV) advertising delivery and measurement platform, announced today that the U.S. Securities and Exchange Commission ("SEC") has declared effective ION's Registration Statement on Form S-4 (the "Registration Statement"), as amended, which was filed in connection with ION's previously announced business combination (the "Business Combination") wi

425 - ION Acquisition Corp 2 Ltd. (0001835378) (Subject)

8-K - ION Acquisition Corp 2 Ltd. (0001835378) (Filer)